Nektar Therapeutics
NKTR
#4582
Rank
S$3.23 B
Marketcap
S$95.82
Share price
-2.12%
Change (1 day)
231.44%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): S-$10.78

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$10.78. In 2025 the company made an earnings per share (EPS) of S-$13.06 a decrease over its 2024 EPS that were of S-$11.34.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$10.78-17.4%
2025S-$13.0615.12%
2024S-$11.34-59.54%
2023S-$28.03-25.89%
2022S-$37.82-31.12%
2021S-$54.9114.86%
2020S-$47.81-1.19%
2019S-$48.38-163.96%
2018S$75.65-725.4%
2017S-$12.10-42.73%
2016S-$21.1283.33%
2015S-$11.5239.53%
2014S-$8.26-69.29%
2013S-$26.88-6.67%
2012S-$28.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.18-203.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.68-115.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.53-271.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$2.73-74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.58-142.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.90-182.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.35-103.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$1.19-111.05%๐Ÿ‡ฎ๐Ÿ‡ช Ireland